Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 145,369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorder Clear all

Conditions: Severe Aplastic Anemia (SAA)
Interventions: Eltrombopag; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 2 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obesity, Inflammation, Nutrition Therapy
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 25 Years to 45 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: ADHD, Attention Difficulties, Mood, Anxiety, Caffeine
Interventions: Proper Wild energy shot; Other
Lead sponsor: Proper Wild, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Major Depression, Healthy Participants
Interventions: Sham iTBS, TMS, D-cycloserine, Dextromethophan, Placebo; Device · Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)
Interventions: Velinotamig specified dose on specified days.; Drug
Lead sponsor: Cullinan Therapeutics Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Webster, Texas

Conditions: Osteoarthritis
Interventions: Dextrose Prolotherapy, Saline Prolotherapy, At-home physical therapy exercise group; Procedure · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 40 Years to 70 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2016
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Spinal Cord Injury
Interventions: ReWalk Rehabilitation 2.0; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 12 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cerebral Palsy
Interventions: Targeted Training for trunk control; Device
Lead sponsor: University of Hartford; Other
Eligibility: 2 Years to 12 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: West Hartford, Connecticut

Conditions: Friedreich Ataxia
Interventions: Spinal tap for CSF collection, Venipuncture for blood sample; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pre-Eclampsia
Interventions: Echocardiogrpahy and non-invasive monitoring; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obesity
Interventions: Roflumilast; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 30 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Down Syndrome, Alzheimer Disease
Interventions: Vitamin E, multivitamin, Placebo; Drug
Lead sponsor: New York State Institute for Basic Research; Government
Eligibility: 50 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2012
U.S. locations: 14
States / cities: Farmington, Connecticut • Tampa, Florida • Atlanta, Georgia + 10 more

Conditions: Blood Pressure, Low Back Pain, Hypertension
Interventions: Permanent Epidural Spinal Cord Stimulation; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Primary Progressive Aphasia
Interventions: Transcranial Direct Current Stimulation (tDCS), Sham tDCS, Modified Contraint-Induced Language Therapy (mCILT); Device · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 45 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hearing Loss, Ear Diseases, Hearing Disorders, Otolaryngological Disease
Interventions: Remote Fitting, In-Office Fitting; Device
Lead sponsor: Advanced Bionics; Industry
Eligibility: 13 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Plasma Cell Myeloma
Interventions: isatuximab SAR650984, Pomalidomide, Dexamethasone, Carfilzomib; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 583 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 24
States / cities: Little Rock, Arkansas • Fullerton, California • San Francisco, California + 21 more

Conditions: Intervertebral Disc Degeneration
Interventions: C5-C6 arthrodesis; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 60 Years
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stress, Anxiety, Depression
Interventions: Exposure to relaxant and stimulant odors; Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 44 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Urinary Tract Infections, Bladder Cancer
Interventions: Vikor Scientific Urine-IDTM; Diagnostic Test
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Dysphagia
Interventions: Pharyngocise; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 90 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Obesity
Interventions: Intralipid, 20% Intravenous Emulsion, Placebos; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Chapel Hill, North Carolina

Conditions: Lymphoma, Leukemia
Interventions: Zevalin Radioimmunotherapy, Rituximab, Fludarabine, Cyclophosphamide, Allogeneic Stem Cell Transplantation; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Esophageal Cancer
Interventions: carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy; Drug · Procedure · Radiation
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: Up to 120 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Becker Muscular Dystrophy
Interventions: Not listed
Lead sponsor: Cooperative International Neuromuscular Research Group; Network
Eligibility: 4 Years and older · Male only
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 13
States / cities: Sacramento, California • Washington D.C., District of Columbia • Gainesville, Florida + 10 more

Search by objective public record fields.

Extended Dosing With Eltrombopag for Severe Aplastic Anemia

Gene Expression and Inflammation in Overweight Subjects

A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Joint Injections for Osteoarthritic Knee Pain

Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

Case Series_Targeted Training for Trunk Control Cerebral Palsy

Measurement of Frataxin mRNA in Biofluids

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Vitamin E in Aging Persons With Down Syndrome

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

Treating Primary Progressive Aphasia (PPA) Using tDCS

Evaluation of Remote Fitting in Adult and Pediatric Users of the HiResolution Bionic Ear System

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Adjacent Segment Mechanics in Cervical Arthrodesis Patients

The Effects of Smell on Mood and Physical Responses

Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture

Pharyngocise Dose Response Study

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping